BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1421445)

  • 21. [Non ulcer dyspepsia, endoscopic gastritis and Helicobacter pylori].
    Rodríguez M; Piñero R; Urrestarazu MI; Serrano N; Poleo JR
    G E N; 1992; 46(1):25-8. PubMed ID: 1305113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inflammatory changes in the gastric mucosa of patients with idiopathic non-ulcer dyspepsia and the effect of colloid bismuth treatment on the course of inflammation].
    Muszyński J; Biernacka D; Stepka M; Galczak A; Zalewski L; Ehrmann A
    Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):79-83. PubMed ID: 1437791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
    Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
    Boixeda D; Gisbert JP; de Rafael L; Alvarez Baleriola I; Martín de Argila C; Bermejo F; García Plaza A
    Med Clin (Barc); 1995 Nov; 105(15):566-9. PubMed ID: 7500675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
    Lokhvitskiĭ SV; Darvin VV; Proshin AV; Bashirova ES; Butorov IL
    Vestn Khir Im I I Grek; 1998; 157(2):18-20. PubMed ID: 9691374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment.
    Sheu BS; Lin CY; Lin XZ; Shiesh SC; Yang HB; Chen CY
    Am J Gastroenterol; 1996 Mar; 91(3):441-7. PubMed ID: 8633488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.
    Hsu PI; Lai KH; Chien EJ; Lin CK; Lo GH; Jou HS; Cheng JS; Chan HH; Hsu JH; Ger LP; Hsu PN; Tseng HH
    Anticancer Res; 2000; 20(2B):1221-8. PubMed ID: 10810425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
    Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N
    Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
    Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients.
    Tucci A; Varoli O; Corinaldesi R; Stanghellini V; Gasperoni S; Paparo GF; Ricci-Maccarini M; La Placa M; Barbara L
    Ital J Gastroenterol; 1993; 25(2):65-7. PubMed ID: 8513165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dyspepsia and Helicobacter (Campylobacter) pylori. Results of a randomized therapeutic trial using amoxicillin versus placebos].
    Pouderoux P; Veyrac M; Amoyal P; Perez C; Barnéon G; Pierrugues R; Parelon G; Blanc F; Michel H
    Ann Gastroenterol Hepatol (Paris); 1991; 27(1):17-9. PubMed ID: 2029180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.
    Xiao SD; Liu WZ; Xia DH; Jiang SJ; Wang RN; Zhang ZH; Xu WW
    Hepatogastroenterology; 1990 Oct; 37(5):503-6. PubMed ID: 2253927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
    Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
    Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.